DBL CYTARABINE 2g/20mL injection vial - medicine shortage information

Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details	Supply Impact Dates	Further Details
DBL CYTARABINE 2g/20mL injection vial AUST R: 47286 Active ingredients: cytarabine Dosage form: Injection, solution Sponsor: Pfizer Australia Pty Ltd Phone: 1800-675-229	From 25 Jan 2027 to 30 Jun 2028	Shortage status: Anticipated Availability: Available Reason: Manufacturing Management action: The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals

Product details

Supply Impact Dates

Further Details

DBL CYTARABINE 2g/20mL injection vial
AUST R: 47286
Active ingredients:
cytarabine

Dosage form:
Injection, solution

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800-675-229

From
25 Jan 2027
to
30 Jun 2028

Shortage status:
Anticipated

Availability:
Available

Reason:
Manufacturing

Management action:
The sponsor is closely controlling the supply. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals